Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05029999
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2021-08-25
Brief Title:
CD40 Agonist Flt3 Ligand and Chemotherapy in HER2 Negative Breast Cancer
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Organization Data
Organization:
University of Texas Southwestern Medical Center
Class:
OTHER
Study ID:
SCCC-03121 STU-2021-0657
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Texas Southwestern Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Sangeetha Reddy
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Texas Southwestern Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gateway for Cancer Research | OTHER |
| Celldex Therapeutics | INDUSTRY |